CAS No.220127-57-1,Imatinib mesylate Suppliers

Products Categories

Pharmaceutical (435)
Organic Chemicals (43)
Others (16)
Reagent (7)
Materials (4)
Plant Extract (4)
(1)
Food Additives (1)
Adhesive and Sealant (1)
Dyestuff and Pigment (1)

Basic Information

Molecular Structure:
CAS No.:	220127-57-1
Name:	Imatinib mesylate
Article Data:	54

Formula:	C₂₉H₃₁N₇O^.CH₄O₃S
Molecular Weight:	589.71
Synonyms:	Benzamide, 4-[ (4-methyl-1-piperazinyl)methyl]-N-[[4- methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, monomethanesulfonate;Matinib mesylate;Imatinib Methanesulfonate;Imatinibmesylate & its intermediates;4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide methanesulfonic acid salt;Veenat;4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3- (4-pyridin-3-yl)-pyrimidin-2-ylamino)-phenyl]-benzamidemethanesulf onic acid salt;methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;
EINECS:	606-892-3
Density:	0.858g/mLat 25°C(lit.)
Melting Point:	214-224°C
Boiling Point:	754.9 °C at 760 mmHg
Flash Point:	410.3 °C
Appearance:	Off-white solid
Hazard Symbols:	Xn
Risk Codes:	22
PSA:	149.03000
LogP:	5.19690

Total:334 Page 1 of 9 1 2 3 4 5 6 …9 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 220127-57-1

Specification

1. Introduction of Imatinib mesylate
Imatinib mesylate is off-white solid. The IUPAC Name of this chemical is Methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide. In addition, its Classification Code is Antineoplastic. Besides, Imatinib mesylate belongs to Active Pharmaceutical Ingredients; Intermediates & Fine Chemicals; Pharmaceuticals; Tyrosine Kinase Inhibitors. Imatinib mesylate is soluble in aqueous buffers ≤ pH 5.5 but is very slightly soluble to insoluble in neutral/alkaline aqueous buffers.

2. Properties of Imatinib mesylate
Physical properties about Imatinib mesylate are:
(1)H-Bond Donor: 3; (2)H-Bond Acceptor: 10; (3)Flash Point: 410.3 °C; (4)Enthalpy of Vaporization: 115.42 kJ/mol; (5)Boiling Point: 754.9 °C at 760 mmHg; (6)Vapour Pressure of Imatinib mesylate (CAS NO.220127-57-1): 6.03E-24 mmHg at 25 °C.

3. Structure Descriptors of Imatinib mesylate
(1)Canonical SMILES: C1N(C)CCN(C1)Cc1ccc(cc1)C(Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C)=O.OS(C)(=O)=O
(2)InChI: InChI=1/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)
(3)InChIKey: InChIKey=YLMAHDNUQAMNNX-UHFFFAOYSA-N
(4)Smiles: C1N(C)CCN(C1)Cc1ccc(cc1)C(Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C)=O.OS(C)(=O)=O

4. Uses of Imatinib mesylate
Imatinib mesylate (CAS NO.220127-57-1) is used as a tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). It can inhibits Bcr-Abl protein-tyrosine kinase.

As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.